POSTER: CML-449 JAK2-Unmutated Erythrocytosis in Chronic Phase Myeloid Leukemia (CP-CML) During Tyrosine Kinase Inhibitor (TKI) Treatment
Open Access
- 30 August 2023
- journal article
- abstracts
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 23, S179